Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Oral baricitinib is effective and safe for treating alopecia areata.

The laser therapy device effectively increased hair growth in people with androgenetic alopecia.

Joint replacement surgery normalized high alkaline phosphatase levels in a patient with severe osteoarthritis.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

The treatment was effective and tolerable for advanced gastric cancer.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Dual wavelength LED caps can safely increase hair density in androgenetic alopecia.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Topical treatment SM04554 safely promotes hair growth in male baldness.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.